https://multiplesclerosisnewstoday.com/news-posts/2023/07/27/three-ms-therapies-have-been-listed-as-who-essential-medicines/
0
0
7/27/23 at 2:12pm
Organization
Multiple Sclerosis News Today
Glatiramer acetate, Mavenclad, and rituximab made the list due to the ability to safely and cost-effectively slow or delay MS progression.
Create an account
or login to join the discussion